Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: Site-dependent effects on REM sleep

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 2, 2012, Pages 373-380

  Monti, Jaime M ^a   Leopoldo, Marcello ^b   Jantos, Héctor ^a   Lagos, Patricia ^c  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b UNIVERSITY OF BARI   (Italy)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

5 HT7 receptor; Basal forebrain; Dorsal raphe nucleus; REM sleep; SB 269970; Serotonin

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; DORSAL RAPHE NUCLEUS; FOREBRAIN; LIGHT DARK CYCLE; MALE; MICROINJECTION; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RAT; REM SLEEP;

ANIMALS; BRAIN STEM; MALE; MICROINJECTIONS; PHENOLS; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SLEEP, REM; SULFONAMIDES;

RATTUS;

EID: 84862199066     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.05.012     Document Type: Article

References (34)

1. Amici R, Sanford LD, Kearney K, McInerney B, Ross RJ, Horner RL, et al. A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat. Brain Res 2004;996:9-18.
2. Argyropoulos SV, Wilson SJ, Nutt DJ. The effects of antidepressant drugs and 5-HT1A agonists on human sleep. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ, editors. Serotonin and sleep: molecular, functional and clinical aspects. Basel: Birkhaüser Verlag; 2008. p. 569-85.
3. Bonaventure P, Kelly P, Aluisio L, Shelton J, Brian Lord, Galaci R, et al. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressantlike behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 2007;321:690-8.
4. Deurveilheur S, Semba K. Basal forebrain regulation of cortical activity and sleep-wake states. Roles of cholinergic and non-cholinergic neurons. Sleep Biol Rhythms 2011;9(Suppl. 1):65-70.
5. Duncan MJ, Grear KE, Hoskins MA. Aging and SB-269970-A, a selective 5-HT7 antagonist, attenuate circadian phase advances induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res 2004;1008:40-8.
6. Gervasoni D, Peyron C, Rampon C, Barbagli B, Chouvet G, Urbain N, et al. Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons. J Neurosci 2000;20:4217-25.
7. Glass JD, Grossman GH, Farnbauch L, DiNardo L.Midbrain raphemodulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J Neurosci 2003;23:7451-60.
8. Guo JD, Hammack SE, Hazra R, Levita L, Rainnie DG. Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience 2009;164:1776-93.
9. Gustafson EL, Dunkin MM, Bard JA, Zgombick J, Branchek TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain. Br J Pharmacol 1996;117:657-66.
10. Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, et al. Characterization of SB- 269970-A, a selective 5-HT7 receptor antagonist. Br J Pharmacol 2000;130:539-48.
11. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ, editors. Serotonin and sleep: molecular, functional and clinical aspects. Basel: Birkhaüser Verlag; 2008. p. 155-82.
12. Hedlund PB. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology 2009;206:345-54.
13. Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG. 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 2005;58:831-7.
14. Leopoldo M, Lacivita E, Berardi F, Perrone R, Hedlund PB. Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther 2011;129:120-48.
15. McKenna JT, Chen L, McCarley RW. Neuronal models of REM-sleep control: evolving concepts. In: Mallick BN, Pandi-Perumal S-R, McCarley RW, Morrison AR, editors. REM sleep: regulation and function. Cambridge: Cambridge University Press; 2011. p. 285-99.
16. Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev 2011;15:269-81.
17. Monti JM, Jantos H. Effects of the 5-HT7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat. Behav Brain Res 2006;167: 245-50.
18. Monti JM, Jantos H, Catenaccio V, Xavier S. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT3 receptor agonist mchlorophenylbiguanide- induced suppression of REM sleep in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1341-8.
19. Neumaier JF, Sexton TJ, Yracheta J, Diaz AM, Brownfield M. Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 2001;21:63-73.
20. Nitz D, Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol 1997;273:R451-5.
21. Paxinos G, Watson C. The rat brain. New York: Academic Press; 2005.
22. Roberts C, Allen L, Langmead CJ, Hagan JJ, Middlemiss DN, Price GW. The effects of SB- 269970, a 5-HT7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol 2001;132:1574-80.
23. Roberts C, Thomas DR, Bate ST, Kew JNC. GABAergic modulation of 5-HT7 receptormediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 2004;46:935-41.
24. Rodrigo-Angulo M, Heredero S, Rodríguez-Veiga E, Reinoso-Suárez F. GABAergic and non-GABAergic thalamic, hypothalamic and basal forebrain projections to the ventral oral pontine reticular nucleus: their implication in REM sleep regulation. Brain Res 2008;1210:116-25.
25. Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, et al. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci U S A 1993;90:8547-51.
26. Semba K. Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behav Brain Res 2000;115:117-41.
27. Semba K. Preoptic and basal forebrain modulation of REM sleep. In: Mallick BN, Pandi- Perumal S-R, McCarley RW, Morrison AR, editors. REM sleep: regulation and function. Cambridge: Cambridge University Press; 2011. p. 99-109.
28. Sharp T, Cowen PJ. 5-HT and depression: is the glass half-full? Curr Opin Pharmacol 2011;11:45-51.
29. Thomas DR. 5-HT7 receptor modulation of sleep patterns. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ, editors. Serotonin and sleep: molecular, functional and clinical aspects. Basel: Birkhaüser Verlag; 2008. p. 439-56.
30. Thomas DR,Melotto S, MassagrandeM, Gribble AD, Jeffrey P, Stevens AJ, et al. SB-656104-A, a novel selective 5-HT7 antagonist, modulates REM sleep in rats. Br J Pharmacol 2003;139:705-14.
31. Vanini G, Lydic R, Baghdoyan HA. GABAergic modulation of REM sleep. In: Mallick BN, Pandi-Perumal S-R, McCarley RW, Morrison AR, editors. REM sleep: regulation and function. Cambridge: Cambridge University Press; 2011. p. 206-13.
32. Wang HL, Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 2009;29:340-58.
33. Wang QP, Ochiai H, Nakai Y. Gabaergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat: studies by electron microscopy double immunostaining. Brain Res Bull 1992;29:943-8.
34. Wesolowska A, Kowalska M. Influence of serotonin 5-HT (7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 2008;60:464-74.